Verrucarin A alters cell-cycle regulatory proteins and induces apoptosis through reactive oxygen species-dependent p38MAPK activation in the human breast cancer cell line MCF-7

Tumor Biology

Volumn 35, Issue 10, 2014, Pages 10159-10167

  Palanivel, Kandasamy ^a   Kanimozhi, Veerasamy ^a   Kadalmani, Balamuthu ^a  

^a BHARATHIDASAN UNIVERSITY   (India)

Author keywords

Apoptosis; Cancer; Cell cycle deregulation; MAPK; ROS; Verrucarin A

Indexed keywords

ANTINEOPLASTIC ANTIBIOTIC; CELL CYCLE PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38; REACTIVE OXYGEN METABOLITE; TRICHOTHECENE DERIVATIVE; VERRUCARIN A;

APOPTOSIS; BREAST TUMOR; CELL CYCLE; DRUG EFFECTS; ENZYME ACTIVATION; FLOW CYTOMETRY; HUMAN; MCF 7 CELL LINE; METABOLISM; MITOCHONDRIAL MEMBRANE POTENTIAL; NICK END LABELING; WESTERN BLOTTING;

ANTIBIOTICS, ANTINEOPLASTIC; APOPTOSIS; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL CYCLE; CELL CYCLE PROTEINS; ENZYME ACTIVATION; FLOW CYTOMETRY; HUMANS; IN SITU NICK-END LABELING; MCF-7 CELLS; MEMBRANE POTENTIAL, MITOCHONDRIAL; P38 MITOGEN-ACTIVATED PROTEIN KINASES; REACTIVE OXYGEN SPECIES; TRICHOTHECENES;

EID: 84922394542     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1007/s13277-014-2286-1     Document Type: Article

References (29)

1. Chin L, Gray JW. Translating insights from the cancer genome into clinical practice. Nature. 2008;452:553–63.
2. Molinari M. Cell cycle checkpoints and their inactivation in human cancer. Cell Prolif. 2000;33:261–74.
3. Andersen B, Nielsen KF, Jarvis BB. Characterization of Stachybotrys from water-damaged buildings based on morphology, growth, and metabolite production. Mycologia. 2002;94:392–403.
4. Oda T, Namikoshi M, Akano K, Kobayashi H, Honma Y, Kasahara T. Verrucarin A inhibition of MAP kinase activation in a PMA-stimulated promyelocytic leukemia cell line. Mar Drugs. 2005;3:64–73.
5. Palanivel K, Kanimozhi V, Kadalmani B, Akbarsha MA. Verrucarin A, a protein synthesis inhibitor, induces growth inhibition and apo-ptosis in breast cancer cell lines MDA-MB-231 and T47D. Biotechnol Lett. 2013;35:1395–403.
6. Chen YW, Huang CF, Yang CY, Yen CC, Tsai KS, Liu SH. Inorganic mercury causes pancreatic beta-cell death via the oxidative stress induced apoptotic and necrotic pathways. Toxicol Appl Pharmacol. 2010;243:323–31.
7. Son YO, Hitron JA, Wang X, Chang QS, Pan JJ, Zhang Z, et al. Cr (VI) induces mitochondrial-mediated and caspase-dependent apopto-sis through reactive oxygen species-mediated p53 activation in JB6 Cl41 cells. Toxicol Appl Pharmacol. 2010;245:226–35.
8. Marsden VS, O'Connor L, O'Reilly LA, Silke J, Metcalf D, Ekert PG. Apoptosis initiated by Bcl-2-regulated caspase activation independently of the cytochrome c/Apaf-1/caspase-9 apoptosome. Nature. 2002;19:634–7.
9. Verma YK, Gangenahalli GU, Singh VK, Gupta P, Chandra R, Sharma RK, et al. Cell death regulation by B-cell lymphoma protein. Apoptosis. 2006;11:459–71.
10. Roy AM, Baliga MS, Elmets CA, Katiyar KS. Grape seed proanthocyanidins induce apoptosis through p53, Bax and caspase-3 pathways. Neoplasia. 2005;7:24–36.
11. Du H, Wolf J, Schafer B, Moldoveanu T,Chipuk JE, KuwanaT. BH3 domains other than Bim and Bid can directly activate Bax/Bak. J Biol Chem. 2011;286:491–501.
12. Suen DF, Norris KL, Youle RK. Mitochondrial dynamics and apo-ptosis. Genes Dev. 2008;22:1577–90.
13. Carvalho H, Evelson P, Sigaud S, Gonzalez-Flecha B. Mitogen-activated protein kinases modulate H(2)O(2)-induced apoptosis in primary rat alveolar epithelial cells. J Cell Biochem. 2004;92:502–13.
14. Jung E, Byun S, Kim S, Kim M, Park D, Lee J. Isomenthone protects human dermal fibroblasts from TNF-alpha-induced death possibly by preventing activation of JNK and p38 MAPK. Food Chem Toxicol. 2012;50:3514–20.
15. Park DH, De Xu H, Shim J, Li YC, Lee JH, Cho SC, et al. Stephania delavayi Diels. inhibits breast carcinoma proliferation through the p38MAPK/NF-kappa B/COX-2 pathway. Oncol Rep. 2011;26:833–41.
16. Valko M, Rhodes CJ, Moncol J, Zakovic M, Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact. 2006;160:1–40.
17. Tamura S, Hanada M, Ohnishi M, Katsura K, Sasaki M, Kobayashi T. Regulation of stress-activated protein kinase signaling pathways by protein phosphatases. Eur J Biochem. 2002;269:1060–6.
18. Cowan KJ, Storey KB. Mitogen-activated protein kinases: new signaling pathways functioning in cellular responses to environmental stress. J Exp Biol. 2003;206:1107–15.
19. Cross TG, Scheel-Toellner D, Henriquez NV, Deacon E, Salmon M, Lord JM. Serine/threonine protein kinases and apoptosis. Exp Cell Res. 2000;256:34–41.
20. Franke TF, Hornik CP, Segev L, Shostak GA, Sugimoto C. PI3K/Akt and apoptosis: size matters. Oncogene. 2003;22:8983–98.
21. Zhang X, Jin B, Huang C. The PI3K/Akt pathway and its downstream transcriptional factors as targets for chemoprevention. Curr Cancer Drug Targets. 2007;7:305–16.
22. Trisciuoglio D, Iervolino A, Zupi G, DelBufalo D. Involvement of PI3K and MAPK signaling in bcl-2-induced vascular endothelial growth factor expression in melanoma cells. Mol Biol Cell. 2005;16:4153–62.
23. Jiang C, Wang Z, Ganther H, Lu J. Distinct effects of methylseleninic acid versus selenite on apoptosis, cell cycle, and protein kinase pathways in DU145 human prostate cancer cells. Mol Cancer Ther. 2002;1:1059–66.
24. Ho A, Dowdy SF. Regulation of G (1) cell-cycle progression by oncogenes and tumor suppressor genes. Curr Opin Genet Dev. 2002;12:47–52.
25. Sherr CJ, Roberts JM. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 1995;9:1149–63.
26. Fulda S, Meyer E, Friesen C, Susin SA, Kroemer G, Debatin M. Cell type specific involvement of death receptor and mitochondrial pathways in drug-induced apoptosis. Oncogene. 2001;20:1063–75.
27. Winters ZE, Lee KRD, Bradburn MJ, Norbury CJ, Harris AL. Cytoplasmic p21WAF1/CIP1 expression is correlated with HER-2/ neu in breast cancer and is an independent predictor of prognosis. Breast Cancer Res. 2003;5:242–9.
28. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D. p21 is a universal inhibitor of cyclin kinases. Nature. 1993;366:701– 4.
29. Mailand N, Gibbs-Seymour I, Bekker-Jensen S. Regulation of PCNA protein interactions for genome stability. Nat Rev Mol Cell Biol. 2013;14:269–82.